These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8580839)

  • 1. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
    Van Doren SR; Kurochkin AV; Hu W; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
    Protein Sci; 1995 Dec; 4(12):2487-98. PubMed ID: 8580839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
    Moy FJ; Chanda PK; Cosmi S; Pisano MR; Urbano C; Wilhelm J; Powers R
    Biochemistry; 1998 Feb; 37(6):1495-504. PubMed ID: 9484219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NMR structure of the inhibited catalytic domain of human stromelysin-1.
    Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Salowe SP; Bush BL; Hermes JD; Esser CK; Hagmann WK; Springer JP
    Nat Struct Biol; 1994 Feb; 1(2):111-8. PubMed ID: 7656014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
    Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY
    J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
    Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD
    Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.
    Li YC; Zhang X; Melton R; Ganu V; Gonnella NC
    Biochemistry; 1998 Oct; 37(40):14048-56. PubMed ID: 9760240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
    Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL
    Structure; 1996 Apr; 4(4):375-86. PubMed ID: 8740360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Skotnicki JS; Wilhelm J; Powers R
    Biochemistry; 1999 Jun; 38(22):7085-96. PubMed ID: 10353819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H; Werle K; Bauer MM; Dollinger H; Jung B
    J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin.
    Gomis-Rüth FX; Kress LF; Kellermann J; Mayr I; Lee X; Huber R; Bode W
    J Mol Biol; 1994 Jun; 239(4):513-44. PubMed ID: 8006965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of Delta 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate.
    Massiah MA; Abeygunawardana C; Gittis AG; Mildvan AS
    Biochemistry; 1998 Oct; 37(42):14701-12. PubMed ID: 9778345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution-state structure by NMR of zinc-substituted rubredoxin from the marine hyperthermophilic archaebacterium Pyrococcus furiosus.
    Blake PR; Park JB; Zhou ZH; Hare DR; Adams MW; Summers MF
    Protein Sci; 1992 Nov; 1(11):1508-21. PubMed ID: 1303769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL; Ruff M; Kannan R; Cuniasse P; Yiotakis A; Dive V; Rio MC; Basset P; Moras D
    J Mol Biol; 2001 Mar; 307(2):577-86. PubMed ID: 11254383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography.
    Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Axel MG; Caldwell CG; Hagmann WK; Becker JW
    J Biomol NMR; 1996 Jan; 7(1):8-28. PubMed ID: 8720828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
    Borkakoti N; Winkler FK; Williams DH; D'Arcy A; Broadhurst MJ; Brown PA; Johnson WH; Murray EJ
    Nat Struct Biol; 1994 Feb; 1(2):106-10. PubMed ID: 7656013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites.
    Yuan P; Marshall VP; Petzold GL; Poorman RA; Stockman BJ
    J Biomol NMR; 1999 Sep; 15(1):55-64. PubMed ID: 10549133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments.
    Van Doren SR; Kurochkin AV; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
    Biochemistry; 1993 Dec; 32(48):13109-22. PubMed ID: 8241165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.